Literature DB >> 24046721

N'-Hy-droxy-pyridine-2-carboximidamide.

P A Suchetan1, S Sreenivasa, B S Palakshamurthy, T Madhu Chakrapani Rao.   

Abstract

The title mol-ecule, C6H7N3O, is almost planar (r.m.s. deviation = 0.0068 Å) and adopts an E conformation about the C=n class="Chemical">N double bond. In the crystal, mol-ecules are linked by pairs of strong N-H⋯N hydrogen bonds, forming inversion dimers with R 2 (2)(10) motifs. The dimers are further linked into C(3) chains through O-H⋯N hydrogen bonds.

Entities:  

Year:  2013        PMID: 24046721      PMCID: PMC3770436          DOI: 10.1107/S1600536813017418

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmaceutical and biological activity of substituted N′-hy­droxy­benzamidines and 1,2,4-oxa­diazole derivatives, see: Kundu et al. (2012 ▶); Sakamoto et al. (2007 ▶); Tyrkov & Sukhenko (2004 ▶). For a related structure, see: Sreenivasa et al. (2012 ▶)

Experimental

Crystal data

C6H7N3O M = 137.15 Monoclinic, a = 21.367 (5) Å b = 4.6382 (11) Å c = 13.003 (3) Å β = 105.468 (12)° V = 1242.0 (5) Å3 Z = 8 Mo Kα radiation μ = 0.11 mm−1 T = 293 K 0.33 × 0.25 × 0.20 mm

Data collection

Bruker APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.966, T max = 0.979 8242 measured reflections 1086 independent reflections 982 reflections with I > 2σ(I) R int = 0.038

Refinement

R[F 2 > 2σ(F 2)] = 0.031 wR(F 2) = 0.081 S = 1.08 1086 reflections 103 parameters 2 restraints H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.19 e Å−3 Δρmin = −0.18 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: APEX2 and SAINT-Plus (Bruker, 2009 ▶); data reduction: SAIn class="Chemical">NT-Plus and XPREP (Bruker, 2009 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: Mercury (Macrae et al., 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536813017418/bt6916sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813017418/bt6916Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813017418/bt6916Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C6H7N3OF(000) = 576
Mr = 137.15prism
Monoclinic, C2/cDx = 1.467 Mg m3
Hall symbol: -C 2ycMo Kα radiation, λ = 0.71073 Å
a = 21.367 (5) ÅCell parameters from 1088 reflections
b = 4.6382 (11) Åθ = 2.0–25.0°
c = 13.003 (3) ŵ = 0.11 mm1
β = 105.468 (12)°T = 293 K
V = 1242.0 (5) Å3Prism, colourless
Z = 80.33 × 0.25 × 0.20 mm
Bruker APEXII CCD area-detector diffractometer1086 independent reflections
Radiation source: fine-focus sealed tube982 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.038
Detector resolution: 1.03 pixels mm-1θmax = 25.0°, θmin = 2.0°
phi and ω scansh = −24→24
Absorption correction: multi-scan (SADABS; Bruker, 2009)k = −5→5
Tmin = 0.966, Tmax = 0.979l = −15→15
8242 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.031Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.081H atoms treated by a mixture of independent and constrained refinement
S = 1.08w = 1/[σ2(Fo2) + (0.0379P)2 + 0.8786P] where P = (Fo2 + 2Fc2)/3
1086 reflections(Δ/σ)max = 0.011
103 parametersΔρmax = 0.19 e Å3
2 restraintsΔρmin = −0.18 e Å3
0 constraints
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.19134 (4)0.1826 (2)0.26040 (7)0.0207 (3)
H1N20.0896 (7)0.225 (3)0.1797 (12)0.027 (4)*
H2N20.0456 (6)0.081 (3)0.0861 (11)0.027 (4)*
H10.2316 (9)0.260 (4)0.2779 (14)0.043 (5)*
C10.12315 (6)−0.2716 (3)0.03188 (9)0.0154 (3)
C20.17439 (6)−0.4236 (3)0.01036 (10)0.0189 (3)
H20.2167−0.39640.05200.023*
C30.16144 (6)−0.6149 (3)−0.07361 (10)0.0208 (3)
H30.1949−0.7164−0.09040.025*
C40.09770 (6)−0.6536 (3)−0.13259 (10)0.0211 (3)
H40.0874−0.7834−0.18910.025*
C50.05004 (6)−0.4948 (3)−0.10538 (10)0.0203 (3)
H50.0073−0.5229−0.14490.024*
C60.13390 (5)−0.0595 (3)0.12070 (9)0.0147 (3)
N10.06133 (5)−0.3023 (2)−0.02561 (8)0.0176 (3)
N20.08163 (5)0.0824 (2)0.13540 (9)0.0179 (3)
N30.19228 (5)−0.0259 (2)0.18081 (8)0.0175 (3)
U11U22U33U12U13U23
O10.0156 (5)0.0240 (5)0.0199 (5)−0.0027 (4)0.0004 (4)−0.0070 (4)
C10.0157 (6)0.0151 (6)0.0149 (6)−0.0009 (5)0.0032 (5)0.0048 (5)
C20.0152 (6)0.0215 (7)0.0186 (6)0.0008 (5)0.0022 (5)0.0038 (5)
C30.0225 (7)0.0210 (7)0.0205 (7)0.0050 (5)0.0087 (5)0.0035 (5)
C40.0276 (7)0.0199 (7)0.0157 (6)0.0005 (5)0.0055 (5)−0.0008 (5)
C50.0175 (6)0.0231 (7)0.0173 (6)−0.0017 (5)−0.0006 (5)−0.0008 (5)
C60.0142 (6)0.0154 (6)0.0141 (6)0.0000 (5)0.0029 (5)0.0046 (5)
N10.0155 (5)0.0193 (6)0.0162 (5)−0.0008 (4)0.0012 (4)0.0004 (4)
N20.0130 (6)0.0216 (6)0.0162 (6)0.0013 (5)−0.0009 (5)−0.0031 (5)
N30.0163 (5)0.0177 (6)0.0169 (5)−0.0009 (4)0.0018 (4)−0.0017 (4)
O1—N31.4201 (13)C4—C51.3773 (18)
O1—H10.903 (18)C4—H40.9300
C1—N11.3407 (16)C5—N11.3408 (16)
C1—C21.3918 (17)C5—H50.9300
C1—C61.4878 (17)C6—N31.2928 (16)
C2—C31.3765 (18)C6—N21.3532 (16)
C2—H20.9300N2—H1N20.862 (13)
C3—C41.3849 (19)N2—H2N20.859 (13)
C3—H30.9300
N3—O1—H1104.9 (11)C3—C4—H4120.9
N1—C1—C2123.03 (11)N1—C5—C4124.19 (12)
N1—C1—C6115.35 (10)N1—C5—H5117.9
C2—C1—C6121.61 (11)C4—C5—H5117.9
C3—C2—C1118.91 (12)N3—C6—N2123.75 (11)
C3—C2—H2120.5N3—C6—C1118.26 (10)
C1—C2—H2120.5N2—C6—C1117.97 (10)
C2—C3—C4118.86 (12)C1—N1—C5116.69 (10)
C2—C3—H3120.6C6—N2—H1N2116.3 (10)
C4—C3—H3120.6C6—N2—H2N2119.9 (10)
C5—C4—C3118.28 (12)H1N2—N2—H2N2118.9 (14)
C5—C4—H4120.9C6—N3—O1108.89 (9)
N1—C1—C2—C3−0.07 (18)N1—C1—C6—N2−0.29 (16)
C6—C1—C2—C3−179.35 (11)C2—C1—C6—N2179.05 (11)
C1—C2—C3—C4−1.19 (18)C2—C1—N1—C51.51 (17)
C2—C3—C4—C50.96 (18)C6—C1—N1—C5−179.17 (10)
C3—C4—C5—N10.6 (2)C4—C5—N1—C1−1.77 (18)
N1—C1—C6—N3178.22 (10)N2—C6—N3—O1−0.96 (16)
C2—C1—C6—N3−2.45 (17)C1—C6—N3—O1−179.38 (9)
D—H···AD—HH···AD···AD—H···A
O1—H1···N3i0.903 (18)1.859 (19)2.7537 (14)170.5 (17)
N2—H2N2···N1ii0.86 (1)2.44 (1)3.1753 (16)144 (1)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
O1—H1⋯N3i 0.903 (18)1.859 (19)2.7537 (14)170.5 (17)
N2—H2N2⋯N1ii 0.86 (1)2.44 (1)3.1753 (16)144 (1)

Symmetry codes: (i) ; (ii) .

  3 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems.

Authors:  Takeshi Sakamoto; Matthew D Cullen; Tracy L Hartman; Karen M Watson; Robert W Buckheit; Christophe Pannecouque; Erik De Clercq; Mark Cushman
Journal:  J Med Chem       Date:  2007-06-19       Impact factor: 7.446

3.  (E)-3-Chloro-N'-hy-droxy-benzene-1-carboximidamide.

Authors:  S Sreenivasa; K E Manojkumar; P A Suchetan; N R Mohan; B S Palakshamurthy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.